A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine.
Sign Up to like & getrecommendations! Published in 2017 at "Vaccine"
DOI: 10.1016/j.vaccine.2016.11.071
Abstract: BACKGROUND University students have high rates of pharyngeal carriage of Neisseria meningitidis. Interruption of carriage acquisition is an important mechanism of vaccines for inducing herd protection. 4CMenB and MenACWY-CRM vaccines have been shown to be… read more here.
Keywords: hsba titers; carriage; vaccination; menacwy crm ... See more keywords
Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old.
Sign Up to like & getrecommendations! Published in 2019 at "Vaccine"
DOI: 10.1016/j.vaccine.2019.10.024
Abstract: INTRODUCTION The quadrivalent meningococcal conjugate vaccine MenACWY-CRM is recommended for 2-23 month-old infants/toddlers at increased risk for meningococcal disease. This study adds to the current knowledge of MenACWY-CRM safety among this age group in a clinical… read more here.
Keywords: infants toddlers; safety; quadrivalent meningococcal; vaccine ... See more keywords
One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea
Sign Up to like & getrecommendations! Published in 2019 at "Clinical and Experimental Vaccine Research"
DOI: 10.7774/cevr.2019.8.2.94
Abstract: Purpose Results from a post-marketing study to generate evidence on 1-year antibody persistence and safety following vaccination of infants from South Korea with the quadrivalent meningococcal conjugate vaccine MenACWY-CRM. Materials and Methods In this phase… read more here.
Keywords: year; post vaccination; vaccination; antibody persistence ... See more keywords